EyePoint financials
$3.42+3.32%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $31.4M | $43.3M | $46.0M | $41.4M | $36.9M | $34.4M | $20.4M | $4.6M |
| Gross profit | $29.3M | $39.6M | $41.4M | $33.1M | $28.8M | $28.6M | $17.7M | $4.6M |
| Gross margin | 93.4% | 91.4% | 89.9% | 79.9% | 77.9% | 83.1% | 86.8% | 100.0% |
| Operating income | -$243.4M | -$145.9M | -$75.1M | -$99.6M | -$55.3M | -$37.3M | -$47.9M | -$39.0M |
| Net income | -$232.0M | -$130.9M | -$70.8M | -$102.3M | -$58.4M | -$45.4M | -$56.8M | -$86.1M |
| Net margin | −739.4% | −302.4% | −153.8% | −247.0% | −158.1% | −131.8% | −278.9% | −1884.2% |
| Diluted EPS | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | $-3.54 | $-5.44 | $-12.70 |
| EBITDA | -$241.1M | -$144.3M | -$74.6M | -$76.5M | -$52.5M | -$34.6M | -$45.3M | -$39.0M |
| Operating cash flow | -$240.1M | -$126.2M | $1.9M | -$65.0M | -$50.1M | -$14.4M | -$56.7M | — |
| Free cash flow | -$243.4M | -$130.3M | -$1.6M | -$67.2M | -$50.3M | -$14.8M | -$56.9M | — |
| Diluted shares | 73.3M | 56.3M | 38.9M | 37.3M | 28.8M | 12.8M | 10.4M | 6.8M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $101.8M | $99.7M | $281.3M | $95.6M | $178.6M | $44.9M |
| Short-term investments | $204.3M | $271.2M | $49.8M | $48.9M | $33.0M | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $39.8M | $36.6M | $38.0M |
| Total assets | $364.0M | $418.5M | $355.2M | $180.4M | $263.4M | $91.7M |
| Total liabilities | $57.9M | $82.0M | $88.9M | $84.0M | $79.0M | $73.2M |
| Shareholders' equity | $306.1M | $336.5M | $266.3M | $96.4M | $184.4M | $18.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology